The Correlation Between the Anxiety and the Amount of the Sweat Gland Secretion in the Patients with Palmar Hyperhidrosis
American Journal of Clinical and Experimental Medicine
Volume 4, Issue 5, September 2016, Pages: 138-145
Received: Jul. 21, 2016; Accepted: Aug. 31, 2016; Published: Sep. 29, 2016
Views 3131      Downloads 84
Authors
Regina Mihardja, Department of Dermatology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Alwi Mappiasse, Department of Dermatology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Anis Irawan Anwar, Department of Dermatology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Arifin Seweng, Department of Biostatistic, Faculty of Public Health, Hasanuddin University, Makassar, Indonesia
Sonny Lisal, Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Andi Wardihan Sinrang, Department of Physiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Article Tools
Follow on us
Abstract
Hyperhidrosis is also known as polyhidrosis or sudorrhea, which defines as the secretion of the sweat that exceeds the amount necessary for thermoregulation of the body. Palmar hyperhidrosis is excessive sweat secretion and is limited to the area of the palm. Anxiety is associated with feelings of uncertainty and helplessness. This emotional state does not have a specific object. Conditions subjectively experienced and communicated in interpersonal relationships. The purpose of this study was to determine the relationship between anxiety with the number of sweat glands secretion in patients with palmar hyperhidrosis. This study was an observational study with cross sectional design and analytical approach, conducted at Outpatient Clinic of Dermatology and Venereology Department of Dr. Wahidin Sudirohusodo Makassar, Hasanuddin University Hospital, and Senior High School in Makassar. This study began in February to April 2016. The number of samples are 40 people who suffered from palmar hyperhidrosis with the largest age distribution that is less than 20 years as many as 26 samples (65.0%). A total of 40 samples (100.0%) do not suffer secondary disorder, experiencing excessive sweating for at least 6 months, lasting at least one week, with bilateral symmetrical distribution, the onset of age 25 or younger and no sweat at night day. Family history of suffering from palmar hyperhidrosis were found in 12 samples (30.0%). There is a daily impact on palmar hyperhidrosis patients as many as 13 samples (32.5%). Students are the most in this study as many as 26 samples (65.0%). The onset of age palmar hyperhidrosis is the most at the age of 13 to 18 years from 21 samples (52.2). The severe palmar hyperhidrosis is the most in this study, there are 16 samples (40.0%). The degrees of moderate anxiety were the most in this study as many as 25 samples (62.5%). In this study, there is a tendency relationship between the degree of anxiety by the number of sweat glands secretion. Norepinephrine associated with severity of palmar hyperhidrosis. The highest level of norepinephrine is in the mild grade of palmar hyperhidrosis. There is a tendency correlation between the score of the Hamilton Rating Scale for Anxiety with blood plasma norepinephrine levels.
Keywords
Palmar Hyperhidrosis, Anxiety, the Number of Sweat Glands Secretion
To cite this article
Regina Mihardja, Alwi Mappiasse, Anis Irawan Anwar, Arifin Seweng, Sonny Lisal, Andi Wardihan Sinrang, The Correlation Between the Anxiety and the Amount of the Sweat Gland Secretion in the Patients with Palmar Hyperhidrosis, American Journal of Clinical and Experimental Medicine. Vol. 4, No. 5, 2016, pp. 138-145. doi: 10.11648/j.ajcem.20160405.15
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Park, E. J., et al., An Epidemiological Study of Hyperhidrosis Patients Visiting the Ajou University Hospital Hyperhidrosis Center in Korea. J Korean Med Sci, 2010. 25: p. 772-775.
[2]
Gross, K. M., et al., Elevated Social Stress Levels and Depressive Symptoms in Primary Hyperhidrosis. Plos One, 2014. 9 (3): p. 1-6.
[3]
Ramos, R., et al., Primary Hyperhidrosis and Anxiety: a Prospective Preoperative Survey of 158 Patients. Arch Bronconeumol, 2005. 41 (2): p. 88-92.
[4]
Lakraj, A.-A. D., N. Moghimi, and B. Jabbari, Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins, 2013. 5: p. 821-840.
[5]
Stefaniak, T. J. and M. Proczko, Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals. Clin Auton Res, 2013. 23: p. 197-200.
[6]
Leon, A., E. C. Levin, and J. Y. M. Koo, Psychodermatology: An Overview. Semin Cutan Med Surg, 2013. 32: p. 64-67.
[7]
Rasmun, Stres, in Stres, Koping dan Adaptasi 2004, Sagung Seto: Jakarta. p. 7-22.
[8]
Hawari, D., Kecemasan, in Manajemen Stres, Cemas dan Depresi 2013, Fakultas Kedokteran Universitas Indonesia: Jakarta. p. 63-83.
[9]
Sherwood, L., Sistem Saraf Perifer: Divisi Eferen, in Human Physiology: From Cells to System 2001, A division of International Thomsom Publishing. p. 196-211.
[10]
Jafferany, M., Psychodermatology: A Guide to Understanding Common Psychocutaneous Disorders. J Clin Psychiatry, 2007. 9: p. 203-213.
[11]
Cohen, S., D. Janicki-Deverts, and G. E. Miller, Psychological Stress and Disease. JAMA, 2007. 298 (14): p. 1685-1687.
[12]
Guyton, A. C. and J. E. Hall, Otonom Medula Adrenal, in Textbook of Medical Physiology, D. Widjajakusumah and A. Tanzil, Editors. 2013, W. B. Saunders Company: Philadelpihia. p. 957-973.
[13]
Wheaton, M. G., A. E. Braddock, and J. S. Abramowitz, The Sweating Cognitions Inventory: A Measure of Cognitions in Hyperhidrosis. J Psychopathol Behav Assess, 2011. 33: p. 393-402.
[14]
Schlereth, T., M. Dieterich, and F. Birklein, Hyperhidrosis - Causes and Treatment of Enhanced Sweating. Dtsch Arztebl Int, 2009. 106 (3): p. 32-37.
[15]
Kalantaria, K. K., et al., The Effect and Persistency of 1% Aluminum Chloride Hexahydrate Iontophoresis in the Treatment of Primary Palmar Hyperhidrosis. IJPR, 2011. 10 (3): p. 641-645.
[16]
Khalid, S. G., Quantification of Hyperhidrosis using Electronic Sudometer, in Quantification of Hyperhidrosis using Electronic Sudometer, B. J. Sjöberg, Editor 2013, Royal Institute of Technology: Sweden. p. 1-43.
[17]
Hamilton, M., The assessment of anxiety states by rating. Br J Med Psychol, 1959. 32: p. 50-55.
[18]
Yazbek, G., et al., Twenty Months of Evolution Following Sympathectomy on Patients with Palmar Hyperhidrosis: Sympathectomy at the T3 Level is Better Than at the T2 Level. Clinics, 2009. 64 (8): p. 743-749.
[19]
Walling, H. W. and B. L. Swick, Treatment Options for Hyperhidrosis. Am J CIln Dermotol, 2011. 12 (5): p. 266-295.
[20]
Leung, A. K. and B. Barankin, Palmar Hyperhidrosis. J Neonatol Clin Pediatr, 2014. 1 (1): p. 1-2.
[21]
Berntsen, B. and R. Gupta, Daily oscillations of sweating in hyperhidrotic individuals before and after treatment with botulinum toxin A. CMAJ, 2006: p. 1-33.
[22]
Haider, A. and N. Solish, Focal hyperhidrosis: diagnosis and management. CMAJ, 2005. 172 (1): p. 1-7.
[23]
Goddard, A. W., et al., Current Perspectives of The Roles of The Central Norephrine Suystem in Anxiety and Depression. Depress Anxiety, 2010. 27: p. 339-350.
[24]
Akbar, T. M., et al., Efficacy and safety of tap water iontophoresis for palmoplantar hyperhidrosis. JPAD, 2013. 23 (3): p. 304-309.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186